Metabolic and biochemical issues in the molecular epidemiology of cancer.
In this chapter, we highlight the significance of some metabolic and biochemical issues in molecular epidemiology. We discuss biomarkers and biologically reactive intermediates and describe the significance of polymorphisms in xenobiotic metabolizing enzymes, with emphasis on the role of some of these enzymes in the generation of reactive metabolites and on the related issue of susceptibility biomarkers. In the final section, we have selected an example of a specific compound, benzene, for which a variety of different biomarkers have been studied.
Snyder
Robert
R
Environmental Occupational Health Sciences Institute, Rutgers University, Piscataway, NJ 08854, USA. rsnyder@eohsi.rutgers.edu
Hong
Jun-Yan
JY
D001554:Benzene / Q000378:metabolism; D015415:Biomarkers; D001711:Biotransformation; D002273:Carcinogens / Q000378:metabolism*; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics / Q000502:physiology; D006801:Humans; D017720:Molecular Epidemiology; D016660:NAD(P)H Dehydrogenase (Quinone) / Q000235:genetics / Q000502:physiology; D009369:Neoplasms / Q000209:etiology* / Q000235:genetics* / Q000378:metabolism; D011110:Polymorphism, Genetic
D015415:Biomarkers; D002273:Carcinogens; D003577:Cytochrome P-450 Enzyme System; D016660:NAD(P)H Dehydrogenase (Quinone); C447479:NQO1 protein, human; D001554:Benzene